Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes
Public ClinicalTrials.gov record NCT03714451. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the effect of onyx sorghum on blood glucose levels in patients with type 2 diabetes (T2DM).
Study identification
- NCT ID
- NCT03714451
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
- onyx sorghum Dietary Supplement
- whole wheat flour Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 30 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2018
- Primary completion
- Dec 19, 2022
- Completion
- Dec 29, 2022
- Last update posted
- Feb 13, 2023
2018 – 2022
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Yale Center for Clinical Investigation | New Haven | Connecticut | 06519 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Diabetes Type 2 trials
Other public records listing Diabetes Type 2. Sorted by last update posted; newest first. Not a recommendation.
- NCT05071898: Pharmacogenetics of Response to GLP1R Agonists Recruiting
- NCT05912647: Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes Recruiting
- NCT07689877: Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study Not yet recruiting
- NCT07376655: Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life Recruiting
- NCT07400653: A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) Recruiting
- NCT07135531: Continuous Glucose Monitoring (CGM) in an Underserved Population Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03714451, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 13, 2023 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03714451 live on ClinicalTrials.gov.